<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>PReferentially Expressed Antigen in MElanoma (PRAME): preliminary communication on a translational tool able to early detect Oral Malignant Melanoma (OMM).-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="PReferentially Expressed Antigen in MElanoma (PRAME): preliminary communication on a translational tool able to early detect Oral Malignant Melanoma (OMM)." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088532/bin/jcav14p0628g001.jpg"/> </div> <div class="text-side"> <h1>PReferentially Expressed Antigen in MElanoma (PRAME): preliminary communication on a translational tool able to early detect Oral Malignant Melanoma (OMM).</h1> <p>Examples of OMM that were strongly immunopositive for PRAME. (A) Histological features of hyperpigmented OMM of the hard palate in a patient with local advanced disease (Hematoxylin-Eosin, Original Magnification 4x, scale bar: 500 µm). (B) Another case of pigmented OMM of the gingiva: note the sheets of melanocytic neoplastic cells (Hematoxylin-Eosin, Original Magnification 10x, scale bar: 250 µm). (C) Photomicrograph corresponding to the case of (A) showing intense and widespread immunoexpression for PRAME (Immunostaining for PRAME, Original Magnification 4x, scale bar: 500 µm). (D) Immunohistochemical preparation of case (B) which also shows strong and widespread positivity of immunostaining for PRAME (Preparation for immunostaining for PRAME, Original Magnification 20x, scale bar: 100 µm).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37057287/" target="_blank">37057287</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>